Macrogenics Inc SEC filings MGNX

Macrogenics Inc has 944 filings in SEC EDGAR's recent list, going back to Nov 12, 2003. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 9, 2026 Dec 31, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 8, 2024 Dec 31, 2023
10-K Annual report Mar 7, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 17, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K/A Amended annual report Mar 2, 2020 Dec 31, 2019
10-K Annual report Feb 25, 2020 Dec 31, 2019
10-K Annual report Feb 26, 2019 Dec 31, 2018
10-K Annual report Feb 27, 2018 Dec 31, 2017
10-K Annual report Feb 28, 2017 Dec 31, 2016
10-K Annual report Feb 29, 2016 Dec 31, 2015
10-K/A Amended annual report Jun 5, 2015 Dec 31, 2014
10-K Annual report Mar 3, 2015 Dec 31, 2014
10-K Annual report Mar 20, 2014 Dec 31, 2013

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MGNX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Rockville, MD
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1125345

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.